Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity

by A. M. Popov, Y. Yu. Verzhbitskaya, G. A. Tsaur, A. G. Solodovnikov, O. R. Arakaev, O. V. Streneva, O. P Khlebnikova, E. V. Shorikov, L. I. Saveliev, S. N. Lagoyko, Yu. V. Rumyantseva, A. I. Karachunskiy, L. G. Fechina
Published 2015-12-01

STANDARDIZATION OF FLOW CYTOMETRIC MINIMAL RESIDUAL DISEASE MONITORING IN CHILDREN WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA. RUSSIA–BELARUS MULTICENTER GROUP EXPERIENCE

by A. M. Popov, M. V. Belevtsev, E. V. Boyakova, T. Yu. Verzhbitskaya, L. V. Movchan, M. S. Fadeeva, А. B. Pashchenko, V. P. Savitskiy, А. A. Levadnyy, G. А. Tsaur, S. A. Kashpor, S. A. Plyasunova, L. G. Fechina, O. V. Aleynikova, A. I. Karachunskiy
Published 2017-01-01

The role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia: literature review and own experience

by Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Published 2018-07-01